UNSPSC 51283938: Salazosulfathiazole

This classification denotes a sulfonamide anti-infective agent, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 56PE10F2EA. The European Medicines Agency schedules Salazosulfathiazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10421MIG. Salazosulfathiazole generally arises in the molecular formula C16H12N4O5S2. The term SALAZOSULFATHIAZOLE is an International Non-Proprietary Name or INN.

SALAZOSULFATHIAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(NC1SCCN1)C1CCC(N/N=C2/C=C(C(=O)C=C2)C(=O)O)CC1.

UNSPSC 51283938 Salazosulfathiazole, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The code nominally covers a specific antimicrobial sulfonamide drug, but the four most recent opportunities posted under this code span naloxone procurement, pharmacy benefit program design, emergency medical supplies for fire departments, and multi-source generic pharmaceutical contracting through cooperative purchasing — none of which involve salazosulfathiazole directly. This mismatch suggests either miscoding in the source data or a tag applied too broadly across pharmaceutical purchasing categories without regard to specific active ingredients.

The issuing bodies reflect typical state and local health and purchasing infrastructure: Seminole County, Florida (health services), the Texas Health and Human Services Commission (state pharmacy benefit management), the City of Tampa (emergency medical services), and the Minnesota Department of Administration on behalf of MMCAP (cooperative purchasing serving state and local facilities across multiple states including Oregon). The most concrete recent opportunity is the City of Tampa's IFB for medical and first aid supplies (Bid 26P00145) due March 13, 2026, with an estimated contract value of $700,000.00 and a Small Local Business Enterprise set-aside; however, this procurement targets fire department emergency response stock, not pharmaceutical manufacturers. The Minnesota MMCAP RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, offers broader pharmaceutical exposure through cooperative purchasing across state and local participants, but again does not specify salazosulfathiazole. The code shows little relevant recent activity under its nominal scope and appears to reflect a downstream procurement categorization that does not match either the code definition or current state and local buying patterns.